Nivolumab
(asked on 22nd November 2016) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, when NICE plans to publish its guidance on the commissioning of Nivolumab for the treatment of breast cancer.
This question was answered on 30th November 2016
The National Institute for Health and Care Excellence has not been asked to develop guidance on nivolumab (Opdivo) for the treatment of breast cancer.
Nivolumab is currently undergoing clinical trials on its potential use as a treatment for breast cancer, but does not currently have a marketing authorisation for use in this indication.